Morgan Stanley Ignores Einhorn, Remains Positive On Athenahealth, Inc

Nearly seven days after David Einhorn announced his short attack on Athenahealth, Inc (NASDAQ:ATHN), a Morgan Stanley report doesn't mention the incident in its May 12 research note on the stock.

Athenahealth: Morgan "overweight," notes potential for cost savings in sales, R&D

The report, which has Athenahealth, Inc (NASDAQ:ATHN) as an “overweight” in the portfolio, noted that “Steady state margins reflect the underlying earnings power of a mature company no longer investing in growth, characterized by lower R&D and sales & marketing spend.”  Although the research note “do not expect it to reach maturity any time soon,” it did say that “hence our 2030 DCF horizon we think a good...